Evaluating Dual Activity LPA Receptor Pan-Antagonist/Autotaxin Inhibitors as Anti-Cancer Agents in Vivo Using Engineered Human Tumors

Prostaglandins and Other Lipid Mediators - United States
doi 10.1016/j.prostaglandins.2009.07.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Engineered Repressors Are Potent Inhibitors of Androgen Receptor Activity

Oncotarget
Oncology
2014English

Non-Peptidic Substrate-Mimetic Inhibitors of Akt as Potential Anti-Cancer Agents

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2009English

Polyamine Analogues as Novel Anti-Her Family Agents in Human Breast Cancer

2008English

The Liver X Receptor Agonist T0901317 Acts as Androgen Receptor Antagonist in Human Prostate Cancer Cells

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2007English

Honokiol as a Specific Collagen Receptor Glycoprotein VI Antagonist on Human Platelets: Functional Ex Vivo and in Vivo Studies

Scientific Reports
Multidisciplinary
2017English

Antitumor Agents. 272. Structure−Activity Relationships and in Vivo Selective Anti-Breast Cancer Activity of Novel Neo-Tanshinlactone Analogues

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Natural Products Used as Anti-Cancer Agents

Journal of Drug Delivery and Therapeutics
2017English

Evaluating Pulmonary Toxicity of Engineered Metal-Based Nanoparticles Using in Vivo and in Vitro Models

English

Role of the Autotaxin-Lpa Pathway in Dexamethasone-Induced Fibrotic Responses and Extracellular Matrix Production in Human Trabecular Meshwork Cells

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy